Skip to main content

Table 3 Mean (Standard Deviation) of PROs at baseline and week 12, and change from baseline to week 12

From: The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study

Measure

Baseline

Week 12

Change1

DLQI Total Score

12.71 (7.18)

5.28 (6.49)

-7.45 (7.78)

SF-36

   

   Physical Functioning

79.26 (24.95)

84.43 (22.62)

5.63 (22.25)

   Role-Physical

72.45 (37.56)

82.50 (34.67)

9.64 (40.30)

   Bodily Pain

59.58 (25.37)

75.87 (24.89)

16.59 (26.90)

   General Health

66.7 (20.6)

72.69 (20.79)

6.10 (16.25)

   Vitality

53.89 (22.81)

61.04 (23.18)

7.60 (20.88)

   Social Functioning

74.49 (27.56)

85.98 (23.63)

11.16 (27.80)

   Role-Emotional

76.03 (35.39)

85.48 (30.77)

8.39 (37.02)

   Mental Health

69.39 (19.30)

77.43 (17.73)

8.14 (18.57)

   Physical Summary Score (PCS)

47.93 (10.23)

51.24 (9.51)

3.47 (9.30)

   Mental Summary Score (MCS)

47.30 (11.23)

51.36 (10.08)

3.94 (11.04)

EQ-5D

   

   Index Score

0.66 (0.28)

0.82 (0.23)

0.16 (0.29)

   VAS Overall Health

72.25 (20.67)

81.22 (17.26)

9.35 (20.71)

  1. 1Change scores are computed only for patients with scores at baseline and Week 12; this number varied between 138 and 140, depending on the specific measure, as compared with the 147 patients at baseline.